ClinicalTrials.gov record
Completed Phase 2 Interventional

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

ClinicalTrials.gov ID: NCT00016393

Public ClinicalTrials.gov record NCT00016393. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer

Study identification

NCT ID
NCT00016393
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • ixabepilone Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2001
Primary completion
Not listed
Completion
Mar 31, 2006
Last update posted
Jun 23, 2013

2001 – 2006

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033-0804
University of California Davis Cancer Center Sacramento California 95817
CCOP - Atlanta Regional Atlanta Georgia 30342-1701
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois 60141
University of Kansas Medical Center Kansas City Kansas 66160-7390
CCOP - Wichita Wichita Kansas 67214-3882
Veterans Affairs Medical Center - Wichita Wichita Kansas 67218
MBCCOP - LSU Health Sciences Center New Orleans Louisiana 70112
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0330
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379
Veterans Affairs Medical Center - Detroit Detroit Michigan 48201-1932
CCOP - Grand Rapids Grand Rapids Michigan 49503
Herbert Irving Comprehensive Cancer Center at Columbia University New York New York 10032
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642
Oregon Cancer Institute Portland Oregon 97201-3098
Veterans Affairs Medical Center - Portland Portland Oregon 97207
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425
CCOP - Upstate Carolina Spartanburg South Carolina 29303
Danville Radiation Therapy Center Memphis Tennessee 38104
Harrington Cancer Center Amarillo Texas 79106
Veterans Affairs Medical Center - Amarillo Amarillo Texas 79106
Brooke Army Medical Center Fort Sam Houston Texas 78234-6200
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900
Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas 78229
CCOP - Scott and White Hospital Temple Texas 76508
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98104
Veterans Affairs Medical Center - Seattle Seattle Washington 98108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00016393, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2013 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00016393 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →